
PG — Investor Relations & Filings
Polaris Group is a biotechnology company dedicated to the development of novel anti-cancer therapies and the provision of Contract Development and Manufacturing Organization (CDMO) services. The company’s core research focuses on ADI-PEG 20 (pegargiminase), a biological agent that utilizes metabolic therapy to target arginine-dependent cancers. This candidate is currently in late-stage clinical development for multiple indications, including mesothelioma, soft tissue sarcoma, and hepatocellular carcinoma. Polaris Group maintains a vertically integrated business model, encompassing drug design, clinical trial management, and internal manufacturing capabilities. It operates cGMP-compliant facilities and has expanded its CDMO portfolio to include complex injectables and synthetic peptides. The company aims to deliver innovative treatment options by leveraging its proprietary technology and global clinical partnerships.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 115年5月背書保證與資金貸與 | 2026-06-10 | Chinese | |
| 115年5月營業收入 | 2026-06-10 | Chinese | |
| 115年05月內部人持股異動(事後) | 2026-06-04 | Chinese | |
| 115年05月董事會成員及持股 | 2026-06-04 | Chinese | |
| 115年年報及股東會資料 — 2026_6550_20260515FE3.pdf | 2026-06-02 | English | |
| 115年年報及股東會資料 — 2026_6550_20260515F05.pdf | 2026-06-02 | Chinese |
Browse filings by year
1 year| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 48026235 | 115年5月背書保證與資金貸與 | 2026-06-10 | Chinese | ||
| 48026234 | 115年5月營業收入 | 2026-06-10 | Chinese | ||
| 47965275 | 115年05月內部人持股異動(事後) | 2026-06-04 | Chinese | ||
| 47965274 | 115年05月董事會成員及持股 | 2026-06-04 | Chinese | ||
| 47936089 | 115年年報及股東會資料 — 2026_6550_20260515FE3.pdf | 2026-06-02 | English | ||
| 47936088 | 115年年報及股東會資料 — 2026_6550_20260515F05.pdf | 2026-06-02 | Chinese | ||
| 47936080 | 115年年報及股東會資料 — 2025_6550_20260515FE4.pdf | 2026-06-02 | English | ||
| 47936078 | 115年年報及股東會資料 — 2025_6550_20260515F04.pdf | 2026-06-02 | Chinese | ||
| 47086827 | 更正本公司民國115年3月之背書保證資訊揭露明細表 | 2026-05-27 | Chinese | ||
| 47008008 | 115年05月僑外投資持股 | 2026-05-25 | Chinese | ||
| 46778021 | 公告本公司114年第二次私募普通股收足股款暨增資基準日 | 2026-05-22 | Chinese | ||
| 46727445 | 公告更正本公司115年董事選任時持股股數 | 2026-05-21 | Chinese | ||
| 46369950 | 115年第1季財務報告書 — 202601_6550_AI1.pdf | 2026-05-14 | Chinese | ||
| 46372318 | 115年第1季大陸投資 | 2026-05-14 | Chinese | ||
| 46372694 | 115年第1季海外子公司投資 | 2026-05-14 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Biosynex
Designs and distributes medical diagnostic solutions, inclu…
|
ALBIO | FR | Manufacturing |
|
BioSyntech, Inc.
Develops advanced biotherapeutic thermogels for tissue repa…
|
BSYI | CA | Manufacturing |
|
BIO-TECHNE Corp
Global supplier of reagents and instruments for research an…
|
TECH | US | Manufacturing |
|
Bioten Co., Ltd
Develops and manufactures natural health foods, cosmetics, …
|
289170 | KR | Manufacturing |
|
Biotest AG
Develops and supplies plasma protein products and biotherap…
|
BIO3 | DE | Manufacturing |
|
Bio-Thera Solutions, Ltd.
Develops innovative therapeutics and biosimilars for oncolo…
|
688177 | CN | Manufacturing |
|
Biotika A.S.
A biotechnology company that manufactures APIs for human an…
|
BSL | SK | Manufacturing |
|
Bioton S.A.
A global manufacturer of recombinant human insulin and diab…
|
BIO | PL | Manufacturing |
|
BIOVENTIX PLC
Develops and supplies sheep monoclonal antibodies for clini…
|
BVXP | GB | Manufacturing |
|
Bioversys N
Clinical-stage biopharma developing antibacterial therapies…
|
BIOV | CH | Manufacturing |
PG via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52582/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52582 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52582 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52582 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52582}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PG (id: 52582)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.